GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bristol-Myers Squibb Co (LIM:BMY) » Definitions » Ending Cash Position

Bristol-Myers Squibb Co (LIM:BMY) Ending Cash Position : $10,875 Mil (As of Mar. 2025)


View and export this data going back to 2020. Start your Free Trial

What is Bristol-Myers Squibb Co Ending Cash Position?

Bristol-Myers Squibb Co's Ending Cash Position for the quarter that ended in Mar. 2025 was $10,875 Mil.

Bristol-Myers Squibb Co's quarterly Ending Cash Position increased from Sep. 2024 ($7,893 Mil) to Dec. 2024 ($10,347 Mil) and increased from Dec. 2024 ($10,347 Mil) to Mar. 2025 ($10,875 Mil).

Bristol-Myers Squibb Co's annual Ending Cash Position increased from Dec. 2022 ($9,325 Mil) to Dec. 2023 ($11,519 Mil) but then declined from Dec. 2023 ($11,519 Mil) to Dec. 2024 ($10,347 Mil).

Bristol-Myers Squibb Co Ending Cash Position Historical Data

The historical data trend for Bristol-Myers Squibb Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bristol-Myers Squibb Co Ending Cash Position Chart

Bristol-Myers Squibb Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14,973.00 14,316.00 9,325.00 11,519.00 10,347.00

Bristol-Myers Squibb Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9,334.00 6,296.00 7,893.00 10,347.00 10,875.00

Bristol-Myers Squibb Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Bristol-Myers Squibb Co's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=11519+-1172
=10,347

Bristol-Myers Squibb Co's Ending Cash Position for the quarter that ended in Mar. 2025 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=10347+528
=10,875

Bristol-Myers Squibb Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Bristol-Myers Squibb Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Bristol-Myers Squibb Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bristol-Myers Squibb Co (LIM:BMY) » Definitions » Ending Cash Position
Comparable Companies
GILD PFE AMGN BIIB OGN AMRN MDCX SCLX MIRA MRK LLY JNJ ABBV OCSE:NOVO B XSWX:ROG XSWX:NOVN LSE:AZN XPAR:SAN TSE:4519 LSE:GSK
Traded in Other Exchanges
BMYMP.PFD:USA BMY:USA BMY:Mexico 1BMY:Italy BRMd:UK 0R1F:UK BRM:Germany BRM:Germany BRM:Germany BRM:Germany BMYB34:Brazil BMYS:Austria BMY:Argentina
Address
Route 206 and Province Line Road, Princeton, New Jersey, NJ, USA, 08543
Website
https://www.bms.com
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.